Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03025529 · ClinicalTrials.gov registry record · NA

Transcranial Stimulation for Essential Tremor

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT03025529: Clinical Trial NA study, sponsored by Beth Israel Deaconess Medical Center.

NCT03025529 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03025529, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

The main purpose of this study is to see if transcranial magnetic stimulation (TMS) can be used to help study brain function in healthy people and in those with neurological diseases like essential tremor. This portion of the study is being done to establish the optimal methods for stimulating the brain to measure its responses.

Primary Outcome

tremor rating scale with questions regarding impact of tremor on activities of daily living and an physician-rated assessment of degree of tremor in hands, head, voice, and while drawing and writing

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • DEVICE Sham Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2015-02
Est. Completion 2016-11-28
Phase NA

Why NCT03025529 stopped before completion

NCT03025529 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT03025529 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03025529 about?

NCT03025529 is a clinical study titled "Transcranial Stimulation for Essential Tremor". The main purpose of this study is to see if transcranial magnetic stimulation (TMS) can be used to help study brain function in healthy people and in those with neurological diseases like essential tremor. This portion of the study is being done to establish the optimal methods for stimulating the b...

What is the current status of trial NCT03025529?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2015-02. Estimated completion is 2016-11-28.

What interventions are being tested in trial NCT03025529?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Sham Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03025529?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03025529's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03025529, the US trial registry maintained by the National Library of Medicine. NCT03025529 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.